34288018|t|The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases.
34288018|a|The sesquiterpene lactone artemisinin from Artemisia annua L. is well established for malaria therapy, but its bioactivity spectrum is much broader. In this review, we give a comprehensive and timely overview of the literature regarding the immunosuppressive activity of artemisinin-type compounds toward inflammatory and autoimmune diseases. Numerous receptor-coupled signaling pathways are inhibited by artemisinins, including the receptors for interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), beta3-integrin, or RANKL, toll-like receptors and growth factor receptors. Among the receptor-coupled signal transducers are extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), AKT serine/threonine kinase (AKT), mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase (ERK) kinase (MEK), phospholipase C gamma1 (PLCgamma), and others. All these receptors and signal transduction molecules are known to contribute to the inhibition of the transcription factor nuclear factor kappa B (NF-kappaB). Artemisinins may inhibit NF-kappaB by silencing these upstream pathways and/or by direct binding to NF-kappaB. Numerous NF-kappaB-regulated downstream genes are downregulated by artemisinin and its derivatives, for example, cytokines, chemokines, and immune receptors, which regulate immune cell differentiation, apoptosis genes, proliferation-regulating genes, signal transducers, and genes involved in antioxidant stress response. In addition to the prominent role of NF-kappaB, other transcription factors are also inhibited by artemisinins (mammalian target of rapamycin [mTOR], activating protein 1 [AP1]/FBJ murine osteosarcoma viral oncogene homologue [FOS]/JUN oncogenic transcription factor [JUN]), hypoxia-induced factor 1alpha (HIF-1alpha), nuclear factor of activated T cells c1 (NF-ATC1), Signal transducers and activators of transcription (STAT), NF E2-related factor-2 (NRF-2), retinoic-acid-receptor-related orphan nuclear receptor gamma (ROR-gammat), and forkhead box P-3 (FOXP-3). Many in vivo experiments in disease-relevant animal models demonstrate therapeutic efficacy of artemisinin-type drugs against rheumatic diseases (rheumatoid arthritis, osteoarthritis, lupus erythematosus, arthrosis, and gout), lung diseases (asthma, acute lung injury, and pulmonary fibrosis), neurological diseases (autoimmune encephalitis, Alzheimer's disease, and myasthenia gravis), skin diseases (dermatitis, rosacea, and psoriasis), inflammatory bowel disease, and other inflammatory and autoimmune diseases. Randomized clinical trials should be conducted in the future to translate the plethora of preclinical results into clinical practice.
34288018	34	45	artemisinin	Chemical	MESH:C031327
34288018	65	101	inflammatory and autoimmune diseases	Disease	MESH:D001327
34288018	107	128	sesquiterpene lactone	Chemical	-
34288018	129	140	artemisinin	Chemical	MESH:C031327
34288018	146	164	Artemisia annua L.	Species	35608
34288018	189	196	malaria	Disease	MESH:D008288
34288018	374	385	artemisinin	Chemical	MESH:C031327
34288018	408	444	inflammatory and autoimmune diseases	Disease	MESH:D001327
34288018	508	520	artemisinins	Chemical	MESH:D037621
34288018	550	563	interleukin-1	Gene	111343
34288018	565	569	IL-1	Gene	111343
34288018	572	599	tumor necrosis factor-alpha	Gene	21926
34288018	601	610	TNF-alpha	Gene	21926
34288018	632	637	RANKL	Gene	21943
34288018	791	814	c-Jun N-terminal kinase	Gene	26419
34288018	816	819	JNK	Gene	26419
34288018	1205	1214	NF-kappaB	Gene	18033
34288018	1217	1229	Artemisinins	Chemical	MESH:D037621
34288018	1242	1251	NF-kappaB	Gene	18033
34288018	1337	1346	NF-kappaB	Gene	18033
34288018	1395	1406	artemisinin	Chemical	MESH:C031327
34288018	1687	1696	NF-kappaB	Gene	18033
34288018	1748	1760	artemisinins	Chemical	MESH:D037621
34288018	1762	1791	mammalian target of rapamycin	Gene	56717
34288018	1793	1797	mTOR	Gene	56717
34288018	1822	1825	AP1	Gene	16476
34288018	1827	1830	FBJ	CellLine	
34288018	1831	1875	murine osteosarcoma viral oncogene homologue	Species	
34288018	1877	1880	FOS	Gene	14281
34288018	1956	1966	HIF-1alpha	Gene	15251
34288018	1969	2007	nuclear factor of activated T cells c1	Gene	18018
34288018	2009	2016	NF-ATC1	Gene	18018
34288018	2078	2100	NF E2-related factor-2	Gene	18024
34288018	2102	2107	NRF-2	Gene	18024
34288018	2311	2322	artemisinin	Chemical	MESH:C031327
34288018	2342	2360	rheumatic diseases	Disease	MESH:D012216
34288018	2362	2382	rheumatoid arthritis	Disease	MESH:D001172
34288018	2384	2398	osteoarthritis	Disease	MESH:D010003
34288018	2400	2419	lupus erythematosus	Disease	MESH:D008180
34288018	2421	2430	arthrosis	Disease	MESH:D010003
34288018	2436	2440	gout	Disease	MESH:D006073
34288018	2443	2456	lung diseases	Disease	MESH:D008171
34288018	2458	2464	asthma	Disease	MESH:D001249
34288018	2472	2483	lung injury	Disease	MESH:D055370
34288018	2489	2507	pulmonary fibrosis	Disease	MESH:D011658
34288018	2510	2531	neurological diseases	Disease	MESH:D020271
34288018	2533	2556	autoimmune encephalitis	Disease	MESH:D020274
34288018	2558	2577	Alzheimer's disease	Disease	MESH:D000544
34288018	2583	2600	myasthenia gravis	Disease	MESH:D009157
34288018	2603	2616	skin diseases	Disease	MESH:D012871
34288018	2618	2628	dermatitis	Disease	MESH:D003872
34288018	2630	2637	rosacea	Disease	MESH:D012393
34288018	2643	2652	psoriasis	Disease	MESH:D011565
34288018	2655	2681	inflammatory bowel disease	Disease	MESH:D015212
34288018	2693	2729	inflammatory and autoimmune diseases	Disease	MESH:D001327
34288018	Negative_Correlation	MESH:D037621	111343
34288018	Positive_Correlation	MESH:D037621	MESH:D009157
34288018	Positive_Correlation	MESH:C031327	MESH:D009157
34288018	Positive_Correlation	MESH:C031327	MESH:D055370
34288018	Negative_Correlation	MESH:C031327	18033
34288018	Negative_Correlation	MESH:D037621	16476
34288018	Negative_Correlation	MESH:D037621	18033
34288018	Negative_Correlation	MESH:D037621	21926
34288018	Negative_Correlation	MESH:D037621	18024
34288018	Negative_Correlation	MESH:D037621	14281
34288018	Negative_Correlation	MESH:C031327	56717
34288018	Negative_Correlation	MESH:C031327	MESH:D001327
34288018	Negative_Correlation	MESH:C031327	MESH:D008288
34288018	Negative_Correlation	MESH:C031327	MESH:D015212
34288018	Negative_Correlation	MESH:D037621	MESH:D000544
34288018	Negative_Correlation	MESH:D037621	21943
34288018	Negative_Correlation	MESH:C031327	MESH:D001172
34288018	Negative_Correlation	MESH:C031327	21926
34288018	Negative_Correlation	MESH:C031327	MESH:D000544
34288018	Negative_Correlation	MESH:D037621	18018

